Fortis Capital Advisors LLC Purchases 230 Shares of Procter & Gamble Company (The) $PG

Fortis Capital Advisors LLC boosted its position in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 14.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,852 shares of the company’s stock after purchasing an additional 230 shares during the period. Fortis Capital Advisors LLC’s holdings in Procter & Gamble were worth $295,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC increased its holdings in Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Nuveen LLC acquired a new position in shares of Procter & Gamble during the 1st quarter worth about $1,954,941,000. Price T Rowe Associates Inc. MD boosted its stake in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after buying an additional 2,466,308 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after buying an additional 2,228,151 shares during the last quarter. Finally, Assenagon Asset Management S.A. boosted its stake in shares of Procter & Gamble by 140.4% during the 1st quarter. Assenagon Asset Management S.A. now owns 2,663,246 shares of the company’s stock worth $453,870,000 after buying an additional 1,555,504 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the transaction, the chief executive officer directly owned 34,978 shares of the company’s stock, valued at $5,532,120.48. This represents a 22.57% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Marc S. Pritchard sold 9,849 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the completion of the transaction, the insider directly owned 182,422 shares in the company, valued at approximately $28,689,507.94. This represents a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. UBS Group set a $180.00 price objective on shares of Procter & Gamble and gave the stock a “buy” rating in a research note on Wednesday, July 30th. Berenberg Bank increased their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research note on Wednesday, September 17th. Barclays cut their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research note on Wednesday. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a research note on Saturday, September 27th. Finally, Wells Fargo & Company cut their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. Eleven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $173.11.

Get Our Latest Analysis on Procter & Gamble

Procter & Gamble Stock Up 0.1%

Procter & Gamble stock opened at $152.19 on Friday. The stock has a market cap of $356.20 billion, a P/E ratio of 23.38, a P/E/G ratio of 4.02 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a twelve month low of $149.91 and a twelve month high of $180.43. The company’s 50-day moving average price is $155.51 and its two-hundred day moving average price is $160.00.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business’s revenue was up 1.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble’s dividend payout ratio is currently 64.98%.

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.